Skip to main content
Signal8

Jeffries Sean

SEC insider (Form 3/4/5 filer). CIK 0001848377. Chief Operating Officer at Design Therapeutics, Inc. (DSGN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in CARLSBAD, CA.

Companies Jeffries Sean has filed insider reports for

  • Design Therapeutics, Inc. (DSGN): Officer, Chief Operating Officer
Jeffries Sean profile photo

Jeffries Sean

CIK: 0001848377

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Design Therapeutics, Inc. logo
DSGN

Design Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jan 2, 2026
    Award

    Stock option (right to buy)

    Direct
    375K shares-
  • Design Therapeutics, Inc. logo
    DSGN

    Design Therapeutics, Inc.

    Jan 2, 2025
    Award

    Stock option (right to buy)

    Direct
    260K shares-

1-2 of 2